Global Bacillus Coagulans Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Bacillus Coagulans Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary.
Bacillus Coagulans report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bacillus Coagulans market is projected to reach US$ 278.7 million in 2034, increasing from US$ 150.5 million in 2022, with the CAGR of 9.1% during the period of 2024 to 2034. Demand from Food and Beverage and Drugs are the major drivers for the industry.
Global key players of Bacillus Coagulans include Kerry, WECARE-PROBIOTICS, Sabinsa, etc. The top three players hold a share about 57%. North America is the largest producer, has a share about 51%, followed by Japan and China, with share 17% and 14%, respectively. The largest market is North America, with a share about 31%, followed by Europe and China, both have a share about 24 percent.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bacillus Coagulans market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Cellular Activity, Application and Regions Listed in the Report
Kerry
Sabinsa
Mitsubishi
Chr. Hansen
Synbiotech Inc.
WECARE-PROBIOTICS
Segment by Cellular Activity
Below 20 Billion CFU/g
20-100 Billion CFU/g
Above 100 Billion CFU/g
Food and Beverage
Drugs
Supplement Products
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bacillus Coagulans market further
Chapter 1Product Definition, Product Cellular Activitys, Volume and Revenue analysis of Each Cellular Activity in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Bacillus Coagulans, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Bacillus Coagulans industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Bacillus Coagulans in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Bacillus Coagulans introduction, etc. Bacillus Coagulans Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Bacillus Coagulans market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Bacillus Coagulans report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bacillus Coagulans market is projected to reach US$ 278.7 million in 2034, increasing from US$ 150.5 million in 2022, with the CAGR of 9.1% during the period of 2024 to 2034. Demand from Food and Beverage and Drugs are the major drivers for the industry.
Global key players of Bacillus Coagulans include Kerry, WECARE-PROBIOTICS, Sabinsa, etc. The top three players hold a share about 57%. North America is the largest producer, has a share about 51%, followed by Japan and China, with share 17% and 14%, respectively. The largest market is North America, with a share about 31%, followed by Europe and China, both have a share about 24 percent.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bacillus Coagulans market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Cellular Activity, Application and Regions Listed in the Report
By Company
Kerry
Sabinsa
Mitsubishi
Chr. Hansen
Synbiotech Inc.
WECARE-PROBIOTICS
Segment by Cellular Activity
Below 20 Billion CFU/g
20-100 Billion CFU/g
Above 100 Billion CFU/g
Segment by Application
Food and Beverage
Drugs
Supplement Products
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bacillus Coagulans market further
Chapter 1Product Definition, Product Cellular Activitys, Volume and Revenue analysis of Each Cellular Activity in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Bacillus Coagulans, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Bacillus Coagulans industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Bacillus Coagulans in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Bacillus Coagulans introduction, etc. Bacillus Coagulans Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Bacillus Coagulans market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices